KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Finished Goods (2016 - 2026)

Zimmer Biomet Holdings has reported Finished Goods over the past 16 years, most recently at $1.8 billion for Q1 2026.

  • For Q1 2026, Finished Goods rose 1.28% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $1.8 billion, up 1.28%, while the annual FY2025 figure was $1.8 billion, 3.41% up from the prior year.
  • Finished Goods for Q1 2026 was $1.8 billion at Zimmer Biomet Holdings, down from $1.8 billion in the prior quarter.
  • Over five years, Finished Goods peaked at $2.0 billion in Q3 2025 and troughed at $1.7 billion in Q4 2022.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2024 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: fell 16.82% in 2022 and later rose 10.65% in 2023.
  • Year by year, Finished Goods stood at $1.7 billion in 2022, then increased by 10.65% to $1.8 billion in 2023, then fell by 3.25% to $1.8 billion in 2024, then increased by 3.41% to $1.8 billion in 2025, then dropped by 2.89% to $1.8 billion in 2026.
  • Business Quant data shows Finished Goods for ZBH at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $2.0 billion in Q3 2025.